We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

176 hedge funds and large institutions have $1.23B invested in Acorda Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 50

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

4% more funds holding

Funds holding: 170 → 176 (+6)

19% less capital invested

Capital invested by funds: $1.51B → $1.23B (-$283M)

75% less call options, than puts

Call options by funds: $2.15M | Put options by funds: $8.69M

Holders
176
Holders Change
+6
Holders Change %
+3.53%
% of All Funds
4.91%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
28
Increased
69
Reduced
50
Closed
21
Calls
$2.15M
Puts
$8.69M
Net Calls
-$6.55M
Net Calls Change
-$6.55M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$35M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25.9M
3
SCM
Scopia Capital Management
New York
+$18.3M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$16.5M
5
Millennium Management
Millennium Management
New York
+$13.7M

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$56.1M
2
TCM
Tekla Capital Management
Massachusetts
-$22.7M
3
EAM
Eagle Asset Management
Florida
-$13.7M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$9.87M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
51
Oxford Asset Management
United Kingdom
$3.67M +$493K +127 +12%
CCMH
52
Cornerstone Capital Management Holdings
New York
$3.46M +$151K +39 +4%
T. Rowe Price Associates
53
T. Rowe Price Associates
Maryland
$3.4M -$6.29M -1,621 -60%
BA
54
BlackRock Advisors
Delaware
$2.98M +$65.9K +17 +2%
Goldman Sachs
55
Goldman Sachs
New York
$2.94M -$5.96M -1,538 -62%
SIM
56
Spark Investment Management
New York
$2.86M – – –
Stifel Financial
57
Stifel Financial
Missouri
$2.82M +$1.2M +309 +53%
1CM
58
1492 Capital Management
Wisconsin
$2.67M +$167K +43 +5%
GTC
59
Ghost Tree Capital
New York
$2.65M +$3.23M +833 New
Prudential Financial
60
Prudential Financial
New Jersey
$2.61M +$38.8K +10 +1%
PAMU
61
Pictet Asset Management (UK)
United Kingdom
$2.46M -$1.76M -454 -37%
State of New Jersey Common Pension Fund D
62
State of New Jersey Common Pension Fund D
New Jersey
$2.39M – – –
ACMM
63
Arbor Capital Management (Minnesota)
Minnesota
$2.36M – – –
Deutsche Bank
64
Deutsche Bank
Germany
$2.23M -$1.27M -328 -32%
CS
65
Credit Suisse
Switzerland
$2.2M -$896K -231 -25%
BG
66
BlackRock Group
United Kingdom
$2.19M -$136K -35 -5%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$2.12M – – –
UBS Group
68
UBS Group
Switzerland
$2.1M -$524K -135 -17%
ARTA
69
A.R.T. Advisors
New York
$2.09M -$3.48M -898 -58%
SI
70
Scout Investments
Missouri
$2.09M – – –
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$2.07M -$3.88K -1 -0.2%
CS
72
Candriam SCA
Luxembourg
$2.04M +$159K +41 +7%
AllianceBernstein
73
AllianceBernstein
Tennessee
$2.02M -$3.88K -1 -0.2%
SEI Investments
74
SEI Investments
Pennsylvania
$1.97M +$1.24M +319 +107%
Wells Fargo
75
Wells Fargo
California
$1.88M -$159K -41 -6%
1 2
3
4 5

ACOR Hedge Fund Activity: Q3 2015 in Review

176 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2015, worth a combined $1.23B — down 19% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 21 closed out — a net gain of 7 holders — while 69 added to existing stakes and 50 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $35M. The largest seller was UBS AM, cutting an estimated $56.1M.

  • 176 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2015, up from 170 in Q2 2015.
  • Funds reported $1.23B of Acorda Therapeutics stock for Q3 2015, down 19% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q3 2015 and 21 closed out, a net change of +7 holders.
  • The largest Acorda Therapeutics buyer in Q3 2015 was Point72 Asset Management, an estimated $35M added.
  • The largest Acorda Therapeutics seller in Q3 2015 was UBS AM, an estimated $56.1M sold.

Based on aggregated 13F filings for Q3 2015.